Idiopathic pulmonary fibrosis (IPF)

New Drug To Treat a Desperate Disease

Author
- Dr. Gifford Jones  Sunday, January 20, 2013
| Print friendly | Email Us

Several months ago I wrote about a tennis partner who was slowly dying of idiopathic pulmonary fibrosis (IPF). We both knew there was no cure for this disease. Nor could I foresee any help for many years. I was wrong on that point. But I was right about my message of hope.

I always tell seriously ill patients the story of the man sentenced to death by the King. Because the King was a lover of horses, the man received a reprieve by promising he’d teach the King’s horse to fly within one year. His friends laughed at him, but he explained, “Within a year the King may die, I may die or the horse may die. Besides, within a year the horse may learn to fly.” The last thing to lose is hope.

Patients with IPF face a grim future. The average length of life from the time of diagnosis of IPF is usually two to five years. Fortunately, fate is occasionally kind, as some patients have lived as long as 20 years.

In some cases the course of the disease remains fairly stable. This was the case of my tennis friend. But then it became apparent that the disease was beginning to progress. During tennis games he developed a dry hacking cough, chest discomfort, but even more ominous, progressive shortness of breath along with weakness and fatigue.

IPF is associated with extensive, progressive, scarring of lung tissue. The alveoli (air sacs) in lungs begin to stiffen and become thick, decreasing the amount of oxygen in the blood stream. In effect, IPF is a slow strangulation of the body’s vital oxygen supply.

During final days any physical activity becomes an extreme effort. As my friend remarked, “It requires hours to do anything. It’s like being trapped under water and trying to surface for air.” It’s easy to understand how doctors treating these cases feel frustrated as there’s little to offer in treatment.

Sir William Olser, one of this country’s greatest physicians, felt this way when a colleague asked how he treated another difficult problem, emphysema. Osler replied, “I send these patients to Egypt”. His startled colleague asked,”Is it for the climate?” “No” Osler replied, “It’s the farthest place I can think of to send them.” It was Osler’s way of saying he had no treatment to offer them.

I had no idea when I wrote about IPF several months ago that in this short interval I’d have good news for some IPF patients. A new medication called. “Esbriet” (pirfenidone) is now available in Germany, France, Sweden, Austria, Denmark, Norway, Iceland, 27 countries in the European Union, and has just been approved by Health Canada.

Dr. Charles Chan, Professor of Medicine and Respirologist at the University of Toronto, once shared Osler’s frustration. But now he’s says “After a decade of failed clinical trials of multiple innovative drugs for IPF, Esbriet is an exciting one for IPF patients. Finally we have a treatment option with proven benefit for patients with this challenging disease.”

Esbriet is designed to fight a two-pronged attack on the underlying problems of idiopathic pulmonary fibrosis, namely the inflammation and tough scarring that eventually choke and kill lung tissue.

Esbriet accomplishes this task by decreasing the formation of cells called fibroblasts that are responsible for triggering scarring and fibrosis of air sacs in the lungs. In addition, Esbriet has an anti-inflammatory effect which helps to slow down the progression of the disease and thereby preserves exercise tolerance.

The usual dose is one oral tablet three times a day. Fortunately, Esbriet is well tolerated by most patients. A few complain of nausea, fatigue, diarrhea and heartburn.

Even if Esbriet had been available several months ago it would not have helped my friend as his IPF was too advanced at that time. But Esbriet can help to decrease the progression of those who suffer from the mild to moderate form of IPF. This is a huge step in the right direction to fight this challenging disease. And Osler would be pleased to know Egypt need no longer be an option.

Disqus Comments

W. Gifford-Jones M.D is the pen name of Dr. Ken Walker graduate of Harvard. Dr. Walker’s website is: docgiff.com.

Dr. Walker can be reached at: .(JavaScript must be enabled to view this email address).

.






Most Shared CFP stories



What's New On CFP:

  1. Latest News on Baltimore Protests
    By News on the Net -- --News Headlines
  2. Latest American News
    By News on the Net -- --News Headlines
  3. Possible Scenarios and Strategic Options vis-à-vis Iran
    By INSS -- --World News
  4. Hispanic Catholics Are Not Conservative
    By Sierra Rayne -- --American Politics
  5. Principles of Constitutionalism: Malum in Se versus Malum Prohibitum
    By Tim Dunkin -- --American Freedom
  6. Turning America into a Battlefield: A Blueprint for Locking Down the Nation
    By John W. Whitehead -- --American Freedom
  7. Alveda King to Baltimore Mayor: My Dear Mayor Stephanie Rawlings-Blake
    By Christian Newswire -- --American Politics
  8. Obama’s Made Some Bad Deals. Why He Should Stop Sidelining Congress.
    By Heritage Foundation -- --American Politics
  9. Always wait for the other shoe to drop
    By Guest Column -- --Letter
  10. Hillary to Use “Two for the Price of One” Pitch in Her Campaign?
    By John Lillpop -- --American Politics
  11. Video: Wheelchair-Bound Woman in Path of Baltimore Riot’s Thrown Projectiles
    By News on the Net -- --Video
  12. Another expensive stimulus project on the rocks
    By James Simpson -- --American Politics
  13. SAF Wins Preliminary Injunction In North Carolina Resident Alien CCW Case
    By Second Amendment Foundation -- --Gun Control - Second Amendment
  14. Fantastic: Russian hackers were reading Obama’s e-mails
    By Dan Calabrese -- --American Politics
  15. Media’s Ongoing Attempts to Downplay VA Scandal
    By Roger Aronoff -- --Media - Media Bias
  16. Clinton Foundation a ‘slush fund’ - lands on watchlist of shady charities
    By Robert Laurie -- --American Politics
  17. Are you a rioter; want to destroy a city?Baltimore’s Dem mayor proud to give you ‘space to do that.’
    By Robert Laurie -- --American Politics
  18. The rules of tolerance: You must bake for gay weddings; you must not host a Ted Cruz event
    By Herman Cain -- --American Politics
  19. Latest World News
    By News on the Net -- --News Headlines
  20. Public Library Faces Lawsuit after Denying Access for Religious Meeting
    By Liberty Counsel -- --Christianity - Religion
  21. A message for Pope Francis
    By Paul Driessen -- --Global Warming-Energy-Environment
  22. It is a bad time to be in the renewable energy industry
    By Marita Noon -- --Global Warming-Energy-Environment
  23. Exclusive: Bakers Facing $135K Fine Over Wedding Cake for Same-Sex Couple Speak Out
    By Heritage Foundation -- --American Politics
  24. ‘W’ rips ‘O’.  What’s wrong with that picture?
    By Judi McLeod -- --Cover Story
  25. The Climate Change Industry and the Hoax of Global Warming
    By Dr. Ileana Johnson Paugh -- --Cover Story
  26. Baltimore mayor supported violence and destruction of property
    By Arthur Weinreb -- --Cover Story
  27. Global Warming? The Pope is Wrong
    By Alan Caruba -- --Cover Story
  28. NPT RevCon 2015: Considerations for Convening a WMDFZ Conference
    By INSS -- --World News
  29. Southern Africa Looks To Prosper From Rich Coal Resource
    By Guest Column -- --Global Warming-Energy-Environment
  30. With the income tax deadline looming, Canadians challenged by an increasingly complex tax system
    By Fraser Institute -- --Financial, Business, Economy












Caruba: Professional Writing Services